RxDoctor Payments Data

Donald Garbett, MD

Vascular & Interventional Radiology · Houston, TXNPI 1285878728

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Inari Medical, Inc. accounts for 72.2% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2022 at $32,136 and has fallen 96.0% since, to $1,290 in 2025. Among vascular & interventional radiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,966in general payments, 2019–2025

Across 306 payments — averaging $251.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$56K
  • Penumbra, Inc.$10K
  • Boston Scientific$3K
  • Terumo Medical Corporation$2K
  • Angiodynamics, Inc.$2K
  • Philips North America LLC$825
  • plus $4K from 25 others

What the payments were for

  • Consulting fees$45,70059%
  • Speaking & faculty fees$4,8006%
  • Travel & lodging$14,04618%
  • Food & beverage$12,30816%
  • Education$1110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,966 in reported general payments places this provider in the 90th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas

Medicare billing

Part B allowed, 2024
$1,318,833
Medicare patients
1,537
Services billed
7,754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone111$800
Ibuprofen96$243
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim103$183
Famotidine86$91

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →